@cindyatwell.bsky.social
Reposted
STAT’s @helenbranswell.bsky.social on the ‘startling’ new U.S. vaccine schedule
‘It’s jaw-dropping for people who work in this field.’
Read more: www.statnews.com/2026/01/07/k...
‘It’s jaw-dropping for people who work in this field.’
Read more: www.statnews.com/2026/01/07/k...
January 7, 2026 at 8:35 PM
STAT’s @helenbranswell.bsky.social on the ‘startling’ new U.S. vaccine schedule
‘It’s jaw-dropping for people who work in this field.’
Read more: www.statnews.com/2026/01/07/k...
‘It’s jaw-dropping for people who work in this field.’
Read more: www.statnews.com/2026/01/07/k...
Reposted
The one validated intervention to slow aging and extend healthspan is not for sale.
It's exercise.
sciencedirect.com/science/arti...
It's exercise.
sciencedirect.com/science/arti...
December 20, 2025 at 6:22 PM
The one validated intervention to slow aging and extend healthspan is not for sale.
It's exercise.
sciencedirect.com/science/arti...
It's exercise.
sciencedirect.com/science/arti...
Reposted
In agreement with my friend @kkjetelina.bsky.social who writes today: "I suggest the general public avoid the CDC website."
yourlocalepidemiologist.substack.com/p/cdc-false-...
www.wsj.com/health/healt...
yourlocalepidemiologist.substack.com/p/cdc-false-...
www.wsj.com/health/healt...
November 21, 2025 at 3:39 PM
In agreement with my friend @kkjetelina.bsky.social who writes today: "I suggest the general public avoid the CDC website."
yourlocalepidemiologist.substack.com/p/cdc-false-...
www.wsj.com/health/healt...
yourlocalepidemiologist.substack.com/p/cdc-false-...
www.wsj.com/health/healt...
Reposted
While the latest GLP-1 medicines are “new” exenatide was approved April 28 2005. Congratulations to John Eng, Amylin Pharma and the hundreds of visionary persistent investigators who gave birth to the class of GLP-1 medicines for type 2 #diabetes
www.youtube.com/watch?v=WiHH...
www.youtube.com/watch?v=WiHH...
April 27, 2025 at 11:13 AM
While the latest GLP-1 medicines are “new” exenatide was approved April 28 2005. Congratulations to John Eng, Amylin Pharma and the hundreds of visionary persistent investigators who gave birth to the class of GLP-1 medicines for type 2 #diabetes
www.youtube.com/watch?v=WiHH...
www.youtube.com/watch?v=WiHH...
Reposted
A baby boy born with a debilitating genetic disease will likely no longer require a liver transplant to stabilize his condition, thanks to an experimental treatment.
Exclusive: First-of-its-kind infant DNA edit leads to apparent cure in disease that set back field 25 years ago
Baby with genetic OTC deficiency shows promising response to iECURE's first-in-kind gene therapy, potentially avoiding liver transplant and normalizing protein metabolism.
endpts.com
January 9, 2025 at 6:38 PM
A baby boy born with a debilitating genetic disease will likely no longer require a liver transplant to stabilize his condition, thanks to an experimental treatment.